Gossamer Bio (GOSS) Stock Forecast & Price Target

Compare

1,177 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GOSS Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Gossamer

Bio

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GOSS Stock 12 Month Forecast

Average Price Target

$11.25

▲(222.35% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Gossamer Bio in the last 3 months. The average price target is $11.25 with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 222.35% change from the last price of $3.49.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","-1":"-$1","3.25":"$3.25","7.5":"$7.5","11.75":"$11.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,3.25,7.5,11.75,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.14,4.052307692307693,4.964615384615385,5.876923076923077,6.78923076923077,7.701538461538462,8.613846153846154,9.526153846153846,10.438461538461539,11.350769230769231,12.263076923076923,13.175384615384615,14.087692307692308,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.14,3.763846153846154,4.387692307692308,5.0115384615384615,5.635384615384615,6.259230769230769,6.883076923076922,7.506923076923076,8.13076923076923,8.754615384615384,9.378461538461538,10.002307692307692,10.626153846153846,{"y":11.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.14,3.513846153846154,3.8876923076923076,4.2615384615384615,4.635384615384615,5.009230769230769,5.383076923076922,5.756923076923076,6.13076923076923,6.504615384615384,6.878461538461538,7.252307692307692,7.626153846153846,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.87,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.9,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.99,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.23,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$15.00

Average Price Target$11.25

Lowest Price Target$8.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yasmeen Rahimi

Piper Sandler

$15

Buy

329.80%

Upside

Reiterated

12/09/25

Piper Sandler Sticks to Its Buy Rating for Gossamer Bio (GOSS)

Patrick Trucchio

H.C. Wainwright

$10

Buy

186.53%

Upside

Reiterated

11/18/25

Gossamer Bio's Seralutinib Advances: Buy Rating Backed by Promising Late-Stage Trials and Expansion

Andreas Argyrides

Oppenheimer

$9→$12

Buy

243.84%

Upside

Reiterated

11/10/25

Gossamer Bio price target raised to $12 from $9 at OppenheimerGossamer Bio price target raised to $12 from $9 at Oppenheimer

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

―

Hold

―

Reiterated

11/09/25

We maintain our Neutral rating and do not assign a price target.

Joseph Schwartz

Leerink Partners

―

Buy

―

Reiterated

09/26/25

Paul Choi

Goldman Sachs

Buy

129.23%

Upside

Reiterated

09/26/25

Gossamer Bio (GOSS) Gets a Buy from Goldman SachsGoldman Sachs analyst Paul Choi reiterated a Buy rating and $8.00 price target on Gossamer Bio Inc. (NASDAQ: GOSS).

Olivia Brayer

Cantor Fitzgerald

―

Buy

―

Reiterated

09/11/25

Cantor says has reinforced conviction on Gossamer Bio ahead of data readoutCantor says has reinforced conviction on Gossamer Bio ahead of data readout

Eliana Merle

UBS

$1.25→$9

Buy

157.88%

Upside

Upgraded

09/10/25

Gossamer Bio upgraded to Buy from Neutral at UBSGossamer Bio upgraded to Buy from Neutral at UBS

Greg Harrison

Scotiabank

$11

Buy

215.19%

Upside

Initiated

07/14/25

Gossamer Bio initiated with an Outperform at ScotiabankGossamer Bio initiated with an Outperform at Scotiabank

Unknown Analyst

Wedbush

Not Ranked

Wedbush

Buy

14.61%

Upside

Reiterated

05/16/25

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

―

Hold

―

Reiterated

05/15/25

We maintain our Neutral rating, and do not assign a price target to GOSS shares…

Unknown Analyst

Wedbush

Not Ranked

Wedbush

Buy

14.61%

Upside

Reiterated

03/14/25

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yasmeen Rahimi

Piper Sandler

$15

Buy

329.80%

Upside

Reiterated

12/09/25

Piper Sandler Sticks to Its Buy Rating for Gossamer Bio (GOSS)

Patrick Trucchio

H.C. Wainwright

$10

Buy

186.53%

Upside

Reiterated

11/18/25

Gossamer Bio's Seralutinib Advances: Buy Rating Backed by Promising Late-Stage Trials and Expansion

Andreas Argyrides

Oppenheimer

$9→$12

Buy

243.84%

Upside

Reiterated

11/10/25

Gossamer Bio price target raised to $12 from $9 at OppenheimerGossamer Bio price target raised to $12 from $9 at Oppenheimer

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

―

Hold

―

Reiterated

11/09/25

We maintain our Neutral rating and do not assign a price target.

Joseph Schwartz

Leerink Partners

―

Buy

―

Reiterated

09/26/25

Paul Choi

Goldman Sachs

Buy

129.23%

Upside

Reiterated

09/26/25

Gossamer Bio (GOSS) Gets a Buy from Goldman SachsGoldman Sachs analyst Paul Choi reiterated a Buy rating and $8.00 price target on Gossamer Bio Inc. (NASDAQ: GOSS).

Olivia Brayer

Cantor Fitzgerald

―

Buy

―

Reiterated

09/11/25

Cantor says has reinforced conviction on Gossamer Bio ahead of data readoutCantor says has reinforced conviction on Gossamer Bio ahead of data readout

Eliana Merle

UBS

$1.25→$9

Buy

157.88%

Upside

Upgraded

09/10/25

Gossamer Bio upgraded to Buy from Neutral at UBSGossamer Bio upgraded to Buy from Neutral at UBS

Greg Harrison

Scotiabank

$11

Buy

215.19%

Upside

Initiated

07/14/25

Gossamer Bio initiated with an Outperform at ScotiabankGossamer Bio initiated with an Outperform at Scotiabank

Unknown Analyst

Wedbush

Not Ranked

Wedbush

Buy

14.61%

Upside

Reiterated

05/16/25

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

―

Hold

―

Reiterated

05/15/25

We maintain our Neutral rating, and do not assign a price target to GOSS shares…

Unknown Analyst

Wedbush

Not Ranked

Wedbush

Buy

14.61%

Upside

Reiterated

03/14/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Gossamer Bio

1 Month

xxx

Success Rate

9/17 ratings generated profit

Average Return

+1.89%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 52.94% of your transactions generating a profit, with an average return of +1.89% per trade.

3 Months

xxx

Success Rate

10/17 ratings generated profit

Average Return

+16.96%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +16.96% per trade.

1 Year

Yasmeen RahimiPiper Sandler

Success Rate

10/13 ratings generated profit

Average Return

+70.63%

reiterated a buy rating 3 days ago

Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +70.63% per trade.

2 Years

xxx

Success Rate

16/17 ratings generated profit

Average Return

+164.73%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +164.73% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GOSS Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GOSS has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GOSS average Analyst price target in the past 3 months is 11.25.

Each month's total comprises the sum of three months' worth of ratings.

GOSS Financial Forecast

GOSS Earnings Forecast

Next quarter’s earnings estimate for GOSS is -$0.18 with a range of -$0.26 to -$0.11. The previous quarter’s EPS was -$0.21. GOSS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GOSS has Performed in-line its overall industry.

GOSS Sales Forecast

Next quarter’s sales forecast for GOSS is $7.52M with a range of $0.00 to $14.47M. The previous quarter’s sales results were $13.29M. GOSS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GOSS has Performed in-line its overall industry.

GOSS Stock Forecast FAQ

What is GOSS’s average 12-month price target, according to analysts?

Based on analyst ratings, Gossamer Bio Inc’s 12-month average price target is 11.25.

What is GOSS’s upside potential, based on the analysts’ average price target?

Gossamer Bio Inc has 222.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GOSS a Buy, Sell or Hold?

Gossamer Bio Inc has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Gossamer Bio Inc’s price target?

The average price target for Gossamer Bio Inc is 11.25. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $8.00. The average price target represents 222.35% Increase from the current price of $3.49.

What do analysts say about Gossamer Bio Inc?

Gossamer Bio Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of GOSS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Gossamer Bio (GOSS) Stock Forecast & Price Target

GOSS Analyst Ratings

GOSS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Gossamer Bio

GOSS Analyst Recommendation Trends

GOSS Financial Forecast

GOSS Earnings Forecast

GOSS Sales Forecast

GOSS Stock Forecast FAQ

Detailed List of Analyst Forecasts